Transpharmation
Transpharmation is a privately held preclinical neuroscience CRO headquartered in Dublin, Ireland, serving pharmaceutical and biotechnology drug discovery teams globally with animal-model studies, EEG, imaging, and PK/PD services leveraging the world's largest laboratory beagle colony.
- Company typePrivate
- Founded2010
- HeadquartersDublin, Ireland
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Transpharmation does
Transpharmation is a privately held preclinical Contract Research Organization (CRO) headquartered in Dublin, Ireland, with commercial operations spanning North America and Europe. Founded in 2010, the company specializes in translational neuroscience drug discovery services, addressing a documented industry challenge of translating preclinical animal-model findings into clinical success for pharmaceutical and biotech sponsors.
The company operates more than 30 service modules spanning CNS disorders (Alzheimer's, Parkinson's, epilepsy, schizophrenia, depression/anxiety, migraine, multiple sclerosis, essential tremor), pain (inflammatory, neuropathic, osteoarthritic), inflammation, metabolic disease, dermatology, abuse liability, psychedelics, medical cannabis, and veterinary research. Its flagship technical asset is access to the world's largest laboratory beagle colony, used to study naturally developing age-related diseases including Alzheimer's-like cognitive decline and osteoarthritic pain. Supporting platforms include the Operant Platform for behavioral testing, EEG and imaging capabilities, PK-Bridge for translational PK/PD linking, the SPIDAR platform for proprietary discovery methodologies, and PXB Mouse Studies for humanized-liver metabolism work. Bioanalytical, molecular biomarker, and safety study services complement the in vivo offering.
Revenue is generated through fee-for-service study contracts with pharmaceutical and biotechnology clients, with pricing determined by study scope, complexity, and duration on a quote basis. The go-to-market model is sales-led B2B, executed through dedicated North American and European phone lines and website contact forms directed at enterprise pharma and biotech buyers. The company is privately held, with no disclosed funding rounds, institutional investors, M&A activity, or named customers in the available data, and headcount sits in the 11-50 range.
Transpharmation firmographics
Firmographics- Name
- Transpharmation
- Legal name
- Transpharmation
- Website
- https://transpharmation.co.uk
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Transpharmation is a privately held preclinical neuroscience CRO headquartered in Dublin, Ireland, serving pharmaceutical and biotechnology drug discovery teams globally with animal-model studies, EEG, imaging, and PK/PD services leveraging the world's largest laboratory beagle colony.
- Ownership category
- akta.pro rank
Transpharmation industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Research and Development in the Physical, Engineering, and Life Sciences (54171), Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL)
- akta.pro secondary industry
- Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
Keywords
Where Transpharmation is headquartered
LocationHeadquarters
- HQ city
- Dublin
- HQ country
- Ireland
- HQ region
- Europe
Markets served
Transpharmation business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Infrastructure, Technology or R&D, Marketing or Sales, Supply Chain
Revenue model
- Contract Research Services: Fee-for-service preclinical neuroscience research contracts with pharmaceutical and biotech companies. Services provided across multiple therapeutic areas including CNS disorders, pain, inflammation, and metabolic diseases. Revenue generated through study contracts with defined deliverables.
Go-to-market motion1 record
Distribution channels3 records
Marketing channels5 records
Transpharmation product offering
Product offeringCore offering
Transpharmation is a preclinical contract research organization (CRO) providing translational biology and drug discovery services to pharmaceutical and biotechnology companies. Services span 30+ therapeutic areas including Alzheimer's, Parkinson's, epilepsy, migraine, depression/anxiety, schizophrenia, multiple sclerosis, pain disorders, inflammation, and metabolic diseases, using validated animal models and proprietary platforms such as the Operant Platform, PK-Bridge, and SPIDAR. Its unique asset is access to the world's largest laboratory beagle colony, enabling studies of naturally developing age-related conditions such as Alzheimer's-like cognitive decline and osteoarthritic pain.
Product overview
Transpharmation is a global preclinical neuroscience Contract Research Organization (CRO) providing translational biology services for drug discovery. The company operates a portfolio of specialized service modules spanning over 30 therapeutic areas including Alzheimer's Disease, Parkinson's Disease, Pain disorders, Psychiatric conditions, Epilepsy, and Multiple Sclerosis. Key platforms include the Operant Platform for behavioral research, PK-Bridge for translational PK/PD linking, and SPIDAR for specialized discovery methodologies. The company is distinguished by access to the largest laboratory beagle colony in the world, enabling studies of naturally developing age-related diseases. Services are delivered as individual modules or integrated programs from start to finish for pharmaceutical and biotech clients.
Differentiator
Problem solved
Functional benefit
Products and services
- Alzheimer's Disease Research Services
- Parkinson's Disease Research Services
- Epilepsy Research Services
- Depression/Anxiety Research Services
- Schizophrenia Research Services
- Migraine Research Services
- Multiple Sclerosis Research Services
- Essential Tremor Research Services
- Abuse Liability / Substance Use Disorders Services
- Medical Cannabis Research Services
- Psychedelics Research Services
- Neuropathic Pain Services
- Inflammatory Pain Services
- Osteoarthritis Research Services
- Inflammation Research Services
- Metabolic Disorders Services
- Dermatology Services
- Veterinary Research Services
- Operant Platform
- PK-Bridge
- SPIDAR
- PK/PD Studies
- CNS Drug Disposition Services
- Safety Studies
- Bioanalytical Studies
- Molecular Biomarkers Services
- Cognitive Assessment Services
- EEG Services
- Imaging Services
- PXB Mouse Studies
Quantifiable outcome
- Access to the largest laboratory beagle colony in the world
- +1 more outcomes
Companies that use Transpharmation
Customer profileSegments3 records
Ideal customer profiles2 records
Transpharmation technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Transpharmation partnerships and signals
Strategic signalScale indicators2 records
Recent moves5 records
Expansion highlights5 records
Transpharmation competitors and assessment
Company assessmentBroad incumbents
- Charles River Laboratories: Global mega-CRO offering end-to-end preclinical and clinical services including extensive CNS/neuroscience capabilities. Comparable as the incumbent broad-line CRO against which specialty neuroscience CROs like Transpharmation compete for the same pharma wallet.
- Eurofins Discovery: Division of Eurofins Scientific providing preclinical discovery and pharmacology services including CNS models. Operates at much larger scale than Transpharmation but competes for similar preclinical outsourcing contracts.
- WuXi AppTec: China-headquartered global CRO/CDMO with large preclinical and CNS research capabilities. A broad incumbent competitor in translational biology services competing with Transpharmation for global pharma preclinical outsourcing dollars.
- Labcorp Drug Development (formerly Covance): One of the largest global CROs offering comprehensive preclinical and clinical services with neuroscience capabilities. An incumbent competitor that competes for the same translational research budgets as Transpharmation.
Direct peers
- PsychoGenics: US-based preclinical CRO specializing in CNS/neuroscience drug discovery using proprietary behavioral platforms (e.g., SmartCube). Directly comparable to Transpharmation as a specialty neuroscience preclinical CRO serving pharma/biotech with in vivo models and translational biology.
- Inotiv: US-based preclinical CRO and research models provider with significant CNS and animal model capabilities, including contract research services. Directly comparable as a specialized preclinical CRO serving pharma/biotech with in vivo pharmacology studies.
- Porsolt: French preclinical CRO offering behavioral pharmacology and CNS efficacy/safety models for pharma drug discovery. Highly comparable to Transpharmation in scope — specialized neuroscience and pain models with global pharma client base and fee-for-service CRO model.
- Sygnature Discovery: UK-based integrated drug discovery CRO with CNS and translational pharmacology capabilities. Comparable mid-size specialty CRO serving pharma/biotech preclinical outsourcing, with similar therapeutic area breadth including neuroscience.
- Crown Bioscience: Global preclinical CRO with translational drug discovery and oncology/CNS capabilities, acquired by JSR Corporation. Comparable to Transpharmation in offering translational preclinical services to pharma/biotech across multiple therapeutic areas.
Emerging players
- Bionova Scientific: Growing preclinical CRO focused on biologics characterization and preclinical services. Less CNS-specialized than Transpharmation but comparable as a smaller specialty CRO competing for outsourced preclinical work from biotech clients.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks5 records
Key highlights6 records
Customer concentration
Transpharmation social profiles
Digital presenceTranspharmation financial estimates
Financial estimateRevenue estimate
Valuation estimate
Transpharmation leadership team
Management profileNumber of profiles
Transpharmation funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Transpharmation M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Transpharmation
What does Transpharmation do?
Transpharmation is a preclinical contract research organization (CRO) providing translational biology and drug discovery services to pharmaceutical and biotechnology companies. Services span 30+ therapeutic areas including Alzheimer's, Parkinson's, epilepsy, migraine, depression/anxiety, schizophrenia, multiple sclerosis, pain disorders, inflammation, and metabolic diseases, using validated animal models and proprietary platforms such as the Operant Platform, PK-Bridge, and SPIDAR. Its unique asset is access to the world's largest laboratory beagle colony, enabling studies of naturally developing age-related conditions such as Alzheimer's-like cognitive decline and osteoarthritic pain.
Is Transpharmation a public or private company?
Transpharmation is a private company. It is classified as unknown and is currently operating.
When was Transpharmation founded?
Transpharmation was founded in 2010. It employs 11 to 50 people.
Where is Transpharmation based?
Transpharmation is headquartered in Dublin, Ireland, in the Europe region.
How does Transpharmation make money?
One revenue line is on record: contract Research Services.
Who are Transpharmation's main competitors?
Broad incumbents on record are Charles River Laboratories, Eurofins Discovery, WuXi AppTec and Labcorp Drug Development (formerly Covance). Direct peers are PsychoGenics, Inotiv, Porsolt, Sygnature Discovery and Crown Bioscience. Bionova Scientific is listed as an emerging player.
Does Transpharmation have an API?
No public API is recorded for Transpharmation.
What industry is Transpharmation in?
Transpharmation's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAL, Specialty Therapeutic-Area CROs (e.g., oncology/rare disease), with a secondary code of HLAGAAAD, Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity). Its NAICS code is 54171 and its SIC code is 8731.